Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 406,555 | 159,395 | 163,353 | 145,534 | 131,534 |
| Cost of Goods | 9,522 | 2,187 | 2,798 | 4,568 | 6,094 |
| Gross Profit | 397,033 | 157,208 | 160,555 | 140,966 | 125,440 |
| Operating Expenses | 137,170 | 127,804 | 131,567 | 120,307 | 130,042 |
| Operating Income | 260,385 | 29,591 | 29,786 | 21,227 | -4,508 |
| Interest Expense | 14,135 | 19,661 | 21,582 | 23,494 | 24,449 |
| Other Income | 1,767 | 2,200 | -1,718 | 3,025 | 2,966 |
| Pre-tax Income | 248,017 | 12,130 | 6,486 | 758 | -25,991 |
| Income Tax | 2,172 | -769 | 1,401 | 726 | 804 |
| Net Income Continuous | 245,845 | 12,899 | 5,085 | 32 | -26,795 |
| Net Income | $245,845 | $12,899 | $5,085 | $32 | $-26,795 |
| EPS Basic Total Ops | 1.18 | 0.06 | 0.02 | 0.00 | -0.13 |
| EPS Basic Continuous Ops | 1.17 | 0.06 | 0.02 | 0.00 | -0.13 |
| EPS Diluted Total Ops | 1.13 | 0.06 | 0.02 | 0.00 | -0.13 |
| EPS Diluted Continuous Ops | 1.13 | 0.06 | 0.02 | 0.00 | -0.13 |
| EPS Diluted Before Non-Recurring Items | 1.12 | 0.06 | 0.15 | 0.00 | -0.13 |
| EBITDA(a) | $259,688 | $29,219 | $28,965 | $20,175 | $-6,959 |